These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32750174)

  • 1. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
    Bajaj JS; Gavis EA; Fagan A; Wade JB; Thacker LR; Fuchs M; Patel S; Davis B; Meador J; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2021 May; 73(5):1688-1700. PubMed ID: 32750174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Bajaj JS; Salzman NH; Acharya C; Sterling RK; White MB; Gavis EA; Fagan A; Hayward M; Holtz ML; Matherly S; Lee H; Osman M; Siddiqui MS; Fuchs M; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2019 Nov; 70(5):1690-1703. PubMed ID: 31038755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
    Bajaj JS; Kassam Z; Fagan A; Gavis EA; Liu E; Cox IJ; Kheradman R; Heuman D; Wang J; Gurry T; Williams R; Sikaroodi M; Fuchs M; Alm E; John B; Thacker LR; Riva A; Smith M; Taylor-Robinson SD; Gillevet PM
    Hepatology; 2017 Dec; 66(6):1727-1738. PubMed ID: 28586116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant gut microbiota related to patterns of drinking and alcohol relapse in patients with alcoholic hepatitis undergoing stool transplant or corticosteroid therapy.
    Philips CA; Ahamed R; Abduljaleel JK; Rajesh S; Tharakan A; Augustine P
    Indian J Gastroenterol; 2023 Oct; 42(5):724-730. PubMed ID: 37548864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.
    Bajaj JS; Kakiyama G; Savidge T; Takei H; Kassam ZA; Fagan A; Gavis EA; Pandak WM; Nittono H; Hylemon PB; Boonma P; Haag A; Heuman DM; Fuchs M; John B; Sikaroodi M; Gillevet PM
    Hepatology; 2018 Oct; 68(4):1549-1558. PubMed ID: 29665102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials.
    Bajaj JS; Shamsaddini A; Fagan A; Sterling RK; Gavis E; Khoruts A; Fuchs M; Lee H; Sikaroodi M; Gillevet PM
    Hepatol Commun; 2021 Feb; 5(2):258-271. PubMed ID: 33553973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-Liver-Brain Axis and Alcohol Use Disorder: Treatment Potential of Fecal Microbiota Transplantation.
    Wolstenholme JT; Duong NK; Brocato ER; Bajaj JS
    Alcohol Res; 2024; 44(1):01. PubMed ID: 38322428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    J Clin Oncol; 2023 Dec; 41(34):5306-5319. PubMed ID: 37235836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation.
    Arteaga-Muller GY; Flores-Treviño S; Bocanegra-Ibarias P; Robles-Espino D; Garza-González E; Fabela-Valdez GC; Camacho-Ortiz A
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.
    Seekatz AM; Theriot CM; Rao K; Chang YM; Freeman AE; Kao JY; Young VB
    Anaerobe; 2018 Oct; 53():64-73. PubMed ID: 29654837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient.
    Bloom PP; Donlan J; Torres Soto M; Daidone M; Hohmann E; Chung RT
    Hepatol Commun; 2022 Aug; 6(8):2079-2089. PubMed ID: 35384391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
    Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.